CLO21-022: Efficacy and Safety Outcomes With Therapies for Stage I-III Merkel Cell Carcinoma (MCC): A Systematic Literature Review

Authors:
David Miller Massachusetts General Hospital, Boston, MA

Search for other papers by David Miller in
Current site
Google Scholar
PubMed Close
 MD, PhD
,
Roberto Palencia Merck KGaA, Darmstadt, Germany

Search for other papers by Roberto Palencia in
Current site
Google Scholar
PubMed Close
 MA
,
Ting Yu EMD Serono, Inc., Rockland, MA; an affiliate of Merck KGaA, Darmstadt, Germany

Search for other papers by Ting Yu in
Current site
Google Scholar
PubMed Close
 MD
,
Amrita Sandhu OPEN VIE (an OPEN Health Company), London, United Kingdom

Search for other papers by Amrita Sandhu in
Current site
Google Scholar
PubMed Close
 MSc
,
Sarah Webb OPEN VIE (an OPEN Health Company), London, United Kingdom

Search for other papers by Sarah Webb in
Current site
Google Scholar
PubMed Close
 PhD
,
Tom Blaikie OPEN VIE (an OPEN Health Company), London, United Kingdom

Search for other papers by Tom Blaikie in
Current site
Google Scholar
PubMed Close
 MChem
, and
Murtuza Bharmal EMD Serono, Inc., Rockland, MA; an affiliate of Merck KGaA, Darmstadt, Germany

Search for other papers by Murtuza Bharmal in
Current site
Google Scholar
PubMed Close
 PhD
Volume/Issue:
Volume 19: Issue 3.5
Online Publication Date:
17 Mar 2021
DOI:
https://doi.org/10.6004/jnccn.2020.7748
Restricted access

Corresponding Author: Murtuza Bharmal, PhD
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2021 by the National Comprehensive Cancer Network 2021
Article Category:
Abstract
Print Publication Date:
20 Mar 2021
Online Publication Date:
17 Mar 2021

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1038 389 60
PDF Downloads 280 0 0
EPUB Downloads 0 0 0